In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
Kevin R. Stone, MD, Founder, ReGen Biologics, talks about advances in knee joint replacement, including stem cell-based therapies. Filmed at FutureMed, in February, 2012, at Singularity University.
Roger Garcia, DO, Medical Director at BodyLogicMD, in Ohio, discusses how epigenetics can help us understand how we can be in control of changes in our gene expression…
Vinod Khosla, founder of Khosla Ventures, former CEO of Sun Microsystems, is a serial entrepreneur who has invested in a broad portfolio of healthtech startups. He discusses his views on…
Larry Smarr, PhD, Founding Director of of CALIT2, ushers in a new era of medicine with 3D visualization software as well as 3D printing. This technology will revolutionize…
John Abele, Co-founder & Director of Boston Scientific, explains how The Serenity Prayer applies to many things in life. He describes its importance and relevance in public health…
B-M-I or Body Mass Index can help determine how much fat is carried in the body. The B-M-I also corresponds to particular weight categories that may indicate certain…
NEW YORK (Reuters Health) – Among patients undergoing liver transplantation for hepatocellular carcinoma, the risk of recurrence is lower when immunosuppression is based on sirolimus rather than calcineurin…
NEW YORK (Reuters Health) – A French team reports some advantages with robot-assisted compared to conventional laparoscopic radical prostatectomy performed via an extraperitoneal approach. “This study did not…
Lee Krug, MD, discusses the current state of mesothelioma treatments as well as new therapies in development. He mentions the possibilities of clinical trials for angiogenesis inhibitors and anti-VEGF antibodies for mesothelioma…
N. Anthony Coles, MD, President and CEO of Onyx Pharmaceuticals, discusses how developments in genomics and personalized medicine can pave the way for the future of drug development.…
